Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, Valentina P, Palcau AC, Manciocco V, Vescovo M, Cotroneo E, Blandino F, Benevolo M, Covello R, Muti P, Strano S, Vidiri A, Fontemaggi G, Pellini R, Blandino G.
Ganci F, et al. Among authors: benevolo m.
Biomark Res. 2024 Mar 5;12(1):32. doi: 10.1186/s40364-024-00576-y.
Biomark Res. 2024.
PMID: 38444004
Free PMC article.